GGrantIndex
Sort

46,585 grants matching heart failure

A Novel, Low-Cost Mobile Metabolic Measurement (M3) System

$965,910
B Eugene Parker · Barron Associates, Inc. · R44 · FY2024 · HL

Enhanced supercooling for extending non-freezing preservation in preclinical porcine and human donor livers

$965,379
Michael John Taylor · Sylvatica Biotech, Inc. · R44 · FY2024 · DK

Long-term Outcomes after Interventions for Congenital Heart Disease

$964,733
Lazaros K Kochilas · Emory University · R01 · FY2020 · HL

Development of a Total Artificial Lung

$964,147
Robert H. Bartlett · University Of Michigan At Ann Arbor · R01 · FY2008 · HL

Chronic Kidney Disease in Children (CKiD)

$964,088
Susan L Furth · Children'S Hosp Of Philadelphia · U01 · FY2017 · DK

Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial

$963,907
Andrew G. Bostom · Rhode Island Hospital · U01 · FY2008 · DK

Unraveling Cytotoxic and Thrombotic Signals in COVID-19

$963,672
Yogen Kanthi · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL

CaMKII signaling in physiology, heart failure and arrhythmias

$963,586
Mark E Anderson · Johns Hopkins University · R35 · FY2022 · HL

Polygenic risk scores and health disparities: the role of blood cells immune response and evolutionary adaptation

$962,304
Yun Li · Univ Of North Carolina Chapel Hill · U01 · FY2024 · HG

A 3-D biomimetic human islet to model beta cell function in health and disease

$961,943
Maike Sander · University Of California, San Diego · UC4 · FY2016 · DK

CTRIP: Genetic Testing to Individualize Management of Common Heart Diseases

$961,148
Gerald W. Dorn · Washington University · RC2 · FY2009 · HL

INvestigations In Gout, Hyperuricemia, and comorbidiTies (INSIGHT) Center of Research Translation (CORT)

$961,116
Kenneth G Saag · University Of Alabama At Birmingham · P50 · FY2019 · AR

Functional role and therapeutic targeting of exosomes and extracellular RNA biomarkers in heart failure

$960,670
Saumya Das · Massachusetts General Hospital · R35 · FY2020 · HL

Leveraging zebrafish models to dissect and enhance heart regeneration

$960,647
Kenneth D Poss · Duke University · R35 · FY2021 · HL

Leveraging zebrafish models to dissect and enhance heart regeneration

$960,647
Kenneth D Poss · Duke University · R35 · FY2020 · HL

Leveraging zebrafish models to dissect and enhance heart regeneration

$960,647
Kenneth D Poss · Duke University · R35 · FY2023 · HL

Leveraging zebrafish models to dissect and enhance heart regeneration

$960,647
Kenneth D Poss · Duke University · R35 · FY2022 · HL

Toxicology in the 21st Century Program (Tox21) - Genomic Toxicology

$960,480
David Gerhold · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR

Endothelial Dysfunction, Oxidative Stress and Risk of Peripheral Arterial Disease

$960,414
Kenneth Jay Mukamal · Beth Israel Deaconess Medical Center · R01 · FY2010 · HL

THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A

$959,347
Josef Coresh · Johns Hopkins University · N01 · FY2022 · HL

Post Cardiac Surgery Hemodynamics Diagnostic Device

$958,929
Anil Kottam · Bridgesource Medical Corporation · R44 · FY2023 · EB

Optimized Ratiometric Voltage-Sensitive Dyes for Cardiac Research, Safety Pharmacology

$958,484
Corey Acker · Potentiometric Probes, Llc · R44 · FY2023 · GM

Cocaine HIV/AIDS, and Antiretrovirals

$957,992
William Lewis · Emory University · R01 · FY2011 · DA

2-HOBA for Treatment of Pulmonary Hypertension

$957,913
John A Rathmacher · Mti Biotech, Inc. · R42 · FY2025 · HL

2-HOBA for Treatment of Pulmonary Hypertension

$957,913
John A Rathmacher · Mti Biotech, Inc. · R42 · FY2024 · HL